Johan Rosell

3.1k total citations · 2 hit papers
44 papers, 2.2k citations indexed

About

Johan Rosell is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Johan Rosell has authored 44 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Johan Rosell's work include Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (16 papers) and Colorectal Cancer Screening and Detection (8 papers). Johan Rosell is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (16 papers) and Colorectal Cancer Screening and Detection (8 papers). Johan Rosell collaborates with scholars based in Sweden, United States and Norway. Johan Rosell's co-authors include Annika Malmström, Roger Henriksson, Roger Stupp, Bjørn Henning Grønberg, Monika E. Hegi, Henrik Schultz, Ufuk Abacıoğlu, Didier Frappaz, Benoît Lhermitte and Christine Marosi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Radiology.

In The Last Decade

Johan Rosell

42 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

2012 866 citations Annika Malmström, Bjørn Henning Grønberg et al. The Lancet Oncology profile →
Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades

2011 549 citations Làszló Tabár, Bedrich Viták et al. Radiology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Johan Rosell	919	831	666	422	359	44	2.2k
Claudio Ghimenton	624 0.7×	630 0.8×	302 0.5×	280 0.7×	124 0.3×	101	1.7k
Ingfrid S. Haldorsen	500 0.5×	436 0.5×	741 1.1×	267 0.6×	800 2.2×	131	3.5k
Kevin Oh	1.2k 1.3×	952 1.1×	826 1.2×	400 0.9×	291 0.8×	90	2.7k
Philippe Thiesse	868 0.9×	482 0.6×	474 0.7×	251 0.6×	183 0.5×	84	1.9k
Lucien Nedzi	2.0k 2.2×	561 0.7×	810 1.2×	136 0.3×	875 2.4×	67	3.1k
Alan Nichol	1.1k 1.2×	413 0.5×	572 0.9×	826 2.0×	712 2.0×	112	2.4k
Fabiola Paiar	1.0k 1.1×	210 0.3×	829 1.2×	721 1.7×	488 1.4×	148	2.8k
Kaitlin M. Woo	1.2k 1.3×	295 0.4×	1.3k 2.0×	153 0.4×	415 1.2×	66	2.7k
Max Seidensticker	788 0.9×	377 0.5×	806 1.2×	279 0.7×	689 1.9×	197	3.1k
Christine Sagan	770 0.8×	164 0.2×	622 0.9×	763 1.8×	468 1.3×	101	2.4k

Countries citing papers authored by Johan Rosell

Since Specialization

Citations

This map shows the geographic impact of Johan Rosell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Rosell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Rosell more than expected).

Fields of papers citing papers by Johan Rosell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Rosell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Rosell. The network helps show where Johan Rosell may publish in the future.

Co-authorship network of co-authors of Johan Rosell

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Rosell. A scholar is included among the top collaborators of Johan Rosell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Rosell. Johan Rosell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fohlin, Helena, Anna Nordenskjöld, Johan Rosell, et al.. (2024). Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up. Acta Oncologica. 63. 535–541. 4 indexed citations

Nordenskjöld, Anna, Helena Fohlin, Johan Rosell, et al.. (2023). Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy. The Breast. 71. 63–68. 2 indexed citations

Smits, Anja, et al.. (2021). Sex Disparities in MGMT Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts. Journal of Clinical Medicine. 10(4). 556–556. 13 indexed citations

Elsir, Tamador, Daniel Hägerstrand, Joseph W. Carlson, et al.. (2016). PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. Oncotarget. 7(45). 72431–72442. 11 indexed citations

Rosell, Johan, et al.. (2016). Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC). SpringerPlus. 5(1). 669–669. 30 indexed citations

Rosell, Johan, et al.. (2016). The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades. Urology. 91. 77–82. 6 indexed citations

Aljabery, Firas, et al.. (2015). PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC Urology. 15(1). 87–87. 38 indexed citations

Rosell, Johan. (2014). Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer. Linköping University Electronic Press eBooks. 3 indexed citations

Sjödahl, Rune, Johan Rosell, & Hans Starkhammar. (2013). Causes of death after surgery for colon cancer-impact of other diseases, urgent admittance, and gender. Scandinavian Journal of Gastroenterology. 48(10). 1160–1165. 3 indexed citations

10.

Malmström, Annika, Bjørn Henning Grønberg, Christine Marosi, et al.. (2012). Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. The Lancet Oncology. 13(9). 916–926. 866 indexed citations breakdown →

11.

Rosell, Johan, et al.. (2012). Bladder Wash Cytology at Diagnosis of Ta-T1 Bladder Cancer Is Predictive for Recurrence and Progression. Urology. 80(3). 625–631. 3 indexed citations

12.

Olsson, Hans, Per Hultman, Johan Rosell, & Staffan Jahnson. (2012). Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours. Scandinavian Journal of Urology. 47(3). 188–195. 26 indexed citations

13.

Rosell, Johan, et al.. (2011). Impact of PINCH expression on survival in colorectal cancer patients. BMC Cancer. 11(1). 103–103. 11 indexed citations

14.

Tabár, Làszló, Bedrich Viták, Chien‐Jen Chen, et al.. (2011). Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades. Radiology. 260(3). 658–663. 549 indexed citations breakdown →

15.

Rosell, Johan, Bo Nordenskjöld, Tommy� Fornander, et al.. (2011). Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial. British Journal of Cancer. 104(6). 899–902. 7 indexed citations

16.

Gao, Jingfang, Gunnar Arbman, Fang Qiao, et al.. (2008). MANBApolymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations. Acta Oncologica. 47(3). 372–378. 4 indexed citations

17.

Aus, Gunnar, David Robinson, Johan Rosell, Gabriel Sandblom, & Eberhard Varenhorst. (2005). Survival in prostate carcinoma—Outcomes from a prospective, population‐based cohort of 8887 men with up to 15 years of follow‐up. Cancer. 103(5). 943–951. 42 indexed citations

18.

Nordenskjöld, Bo, Johan Rosell, Lars‐Erik Rutqvist, et al.. (2005). Coronary Heart Disease Mortality After 5 Years of Adjuvant Tamoxifen Therapy: Results from a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(21). 1609–1610. 53 indexed citations

19.

Sandblom, Gabriel, Eberhard Varenhorst, Owe Löfman, Johan Rosell, & Per Carlsson. (2004). Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden. European Urology. 46(6). 717–724. 65 indexed citations

20.

Aus, Gunnar, et al.. (2003). Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer—A Prospective Study Based on Data from a Swedish Population-Based Cohort. European Urology. 43(6). 627–631. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact